Kekule’s line of products are vast and varied. Covering a wide array of therapeutic areas, our products range from key intermediates for nizatidine to bicalutamide to celecoxib. With a strong emphasis on innovative and efficient process development, our products conform to the highest standards of quality that we have set for ourselves. Kekule has an in-house designing and fabrication unit that helps us design process equipment to meet the requirements of our novel processes. This unique combination ensures that the lag time from concept through the pilot scale and final production phase is kept to a minimum.

Equipped with a wide array of process equipment that include glass-lined, lead bonded, SS reactors of various capacities, all-glass distillation and condensation columns combined with peripherals that allow us to operate at temperatures ranging from -15C to 300C and pressure up to 25kg/Sq.cm and a vacuum up to 1 torr, Kekule has the required capacity, expertise and commitment to meet your demands.

Oncology Product List

S.No Product CAS No Therapeutic Category Status Documentation Status
1 Abiraterone Acetate 154229-18-3 Oncology Commercialized CTD DMF
2 Bicalutamide 90357-06-5 Oncology Commercialized CTD DMF/CEP
3 Bortezomib 179324-69-7 Oncology Commercialized Tech Pack
4 Busulphan 55-98-1 Oncology Commercialized Tech Pack
5 Capecitabine 154361-50-9 Oncology Commercialized CTD DMF
6 Chlorambucil 305-03-3 Oncology Commercialized CTD DMF
7 Cyclophosphamide 50-18-0 Oncology Commercialized CTD DMF
8 Cytarabine 147-94-4 Oncology Commercialized CTD DMF
9 Dacarbazine 04-03-4342 Oncology Commercialized CTD DMF
10 Gefitinib 184475-35-2 Oncology Commercialized CTD DMF
11 Gemcitabine HCl 95058-81-4 Oncology Commercialized CTD DMF
12 Ifosfamide (Non-sterile) 3778-73-2 Oncology Under Development Tech Pack
13 Imatinib Mesylate 152459-95-5 Oncology Commercialized CTD DMF
14 Irinotecan HCl 97682-44-5 Oncology Commercialized CTD DMF
15 Melphalan 148-82-3 Oncology Commercialized CTD DMF
16 Nintedanib Esylate 656247-18-6 Oncology Commercialized CTD DMF
17 Nilutamide 63612-50-0 Oncology Commercialized CTD DMF/USDMF/WC
18 Pazopanib HCl 635702-64-6 Oncology Commercialized CTD DMF
19 Pemetrexed Disodium Heptahydrate 137281-23-3 Oncology Commercialized CTD DMF
20 Lapatinib Ditosylate 231277-92-2 Oncology Commercialized CTD DMF
21 Temozolamide 85622-93-1 Oncology Commercialized Tech Pack
22 Zoledronic Acid 118072-93-8 Oncology Commercialized CTD DMF

Non-Oncology Product list

S.No Product CAS No Therapeutic Category Status Documentation Status
1 Benfotiamine 22457-89-2 Dietary supplement Commercialized CTD DMF
2 Celecoxib 169590-42-5 Anti-Inflammatory Commercialized CTD DMF
3 Citalopram HBr 59729-32-7 Anti-Depressant Commercialized CTD DMF
4 Etoricoxib 202409-33-4 Anti-Inflammatory Commercialized CTD DMF
5 Famotidine 76824-35-6 Anti-Ulcerative Commercialized CTD DMF
6 Pantoprazole Sodium 138786-67-1 Anti-Ulcerative Commercialized CTD DMF
7 Quetiapine Fumarate 111974-72-2 Anti-Depressant Commercialized CTD DMF
8 Telmisartan 25148-68-9 Cardiovascular Agent Commercialized Tech Pack
9 Tofacitinib Citrate 540737-29-9 Anti-Inflammatory Commercialized CTD DMF